{"disease":{"id":"hypertriglyceridemia","name":"Hypertriglyceridemia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":20,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"atorvastatin","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"atorvastatin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA reductase inhibitor (statin)","quality_score":77,"revenue":"1000.0","mechanism":"Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis."},{"drug_id":"omega","indication_name":"Severe Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"omega","company_name":"Gachon University Gil Medical Center","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"omega-3","indication_name":"Severe Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Omega 3","company_name":"Assiut University","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl1496","indication_name":"Treat hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ROSUVASTATIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"caduet","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caduet","generic_name":"Amlodipine Besylate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channel","drug_class":"Dihydropyridine calcium channel blocker","quality_score":76,"revenue":null,"mechanism":"Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle."},{"drug_id":"inositol","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inosital","generic_name":"INOSITOL","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"inositol","quality_score":null,"revenue":null,"mechanism":"Inosital works by influencing the metabolism of lipids in the body."},{"drug_id":"nicotinic-acid","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Niaspan","generic_name":"Nicotinic Acid","company_name":"Medpointe Pharm Hlc","drug_phase":"marketed","molecular_target":"Hydroxycarboxylic acid receptor 2","drug_class":"Non-Standardized Food Allergenic Extract [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"omega-3-carboxylic-acids","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epanova","generic_name":"OMEGA-3-CARBOXYLIC ACIDS","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"","drug_class":"Omega-3 Fatty Acid","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"ciprofibrate","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipanor","generic_name":"CIPROFIBRATE","company_name":"Winthrop Pharmaceuticals UK Limited","drug_phase":"marketed","molecular_target":"Peroxisome proliferator-activated receptor alpha","drug_class":"ciprofibrate","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"niaspan","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Niaspan","company_name":"Cedars-Sinai Medical Center","drug_phase":"marketed","molecular_target":"Hydroxycarboxylic acid receptor 3, Nicotinate-nucleotide pyrophosphorylase [carboxylating], Nicotinamide N-methyltransferase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"simvastatin","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zocor","generic_name":"simvastatin","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 4 group A member 2, 3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"HMG-CoA Reductase Inhibitor [EPC]","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"vascepa","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Vascepa","company_name":"University of Louisville","drug_phase":"marketed","molecular_target":"Diacylglycerol O-acyltransferase 1","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"myoinositol","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Myoinositol","company_name":"University of Colorado, Denver","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"omega","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"omega","company_name":"Gachon University Gil Medical Center","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"niacin","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nicotinic Acid","generic_name":"NIACIN","company_name":"MEDPOINTE PHARM HLC","drug_phase":"marketed","molecular_target":"NAD synthase","drug_class":"Vitamin C [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"gemfibrozil","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopid","generic_name":"GEMFIBROZIL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Transthyretin","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"fenofibrate","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tricor (Micronized)","generic_name":"FENOFIBRATE","company_name":"Salix","drug_phase":"marketed","molecular_target":"PPARα","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Fenofibrate activates PPARα, enhancing lipolysis and reducing triglycerides, while increasing HDL-cholesterol and uric acid excretion."},{"drug_id":"rosuvastatin","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Crestor","generic_name":"rosuvastatin","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA reductase inhibitor (statin)","quality_score":74,"revenue":null,"mechanism":"Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme converting HMG-CoA to mevalonate, a cholesterol precursor."},{"drug_id":"lipitor","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"Atorvastatin Calcium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"atorvastatin","quality_score":10,"revenue":null,"mechanism":"Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis."},{"drug_id":"icosapent-ethyl","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vascepa","generic_name":"ICOSAPENT ETHYL","company_name":"Amarin Pharms","drug_phase":"marketed","molecular_target":"Diacylglycerol O-acyltransferase 1","drug_class":"icosapent ethyl","quality_score":43,"revenue":null,"mechanism":""},{"drug_id":"choline-fenofibrate","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trilipix","generic_name":"CHOLINE FENOFIBRATE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Fatty acid-binding protein, intestinal","drug_class":"Peroxisome Proliferator Receptor alpha Agonist","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"lovastatin","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mevacor","generic_name":"LOVASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"HMG-CoA Reductase Inhibitor","quality_score":null,"revenue":null,"mechanism":"Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver."},{"drug_id":"cholestyramine","indication_name":"Hypertriglyceridemia with Elevated LDL","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Questran Light","generic_name":"CHOLESTYRAMINE","company_name":"Bristol Myers","drug_phase":"marketed","molecular_target":"","drug_class":"Bile Acid Sequestrant [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"epanova","indication_name":"Hypertriglyceridemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epanova","company_name":"AstraZeneca","drug_phase":"phase_3","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":24,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06104943","title":"Stockholm hyperTRIglyceridemia REGister (STRIREG) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3607819,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT03415152","title":"A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Abbott","has_results":true},{"nct_id":"NCT06206759","title":"Vitamin C Administration and Triglycerides Level in Critical Care Patients","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT05610280","title":"A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1478,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04650152","title":"Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Abbott","has_results":false},{"nct_id":"NCT06976099","title":"Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05079919","title":"A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":617,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03693131","title":"Efficacy of MND-2119 in Participants With Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Mochida Pharmaceutical Company, Ltd.","has_results":false},{"nct_id":"NCT03001817","title":"Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":551,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true},{"nct_id":"NCT03011450","title":"Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":471,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true},{"nct_id":"NCT05552326","title":"A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":446,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02463071","title":"AZD0585 Phase III Long-term Study in Japan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":383,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT02009865","title":"Epanova® for Lowering Very High Triglycerides II (EVOLVE II)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":379,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07004777","title":"Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition","phase":"NA","overall_status":"RECRUITING","enrollment_count":375,"lead_sponsor_name":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","has_results":false},{"nct_id":"NCT04239950","title":"Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":316,"lead_sponsor_name":"Mochida Pharmaceutical Company, Ltd.","has_results":false},{"nct_id":"NCT03120299","title":"The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":309,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03361501","title":"A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":278,"lead_sponsor_name":"Grace Therapeutics Inc.","has_results":false},{"nct_id":"NCT00246701","title":"Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03398005","title":"A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Grace Therapeutics Inc.","has_results":false},{"nct_id":"NCT05883865","title":"Safety Study of Fenofibrate During Pregnancy","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT04365400","title":"Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":233,"lead_sponsor_name":"Afimmune","has_results":true},{"nct_id":"NCT04720534","title":"Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":true},{"nct_id":"NCT03501680","title":"Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT00903409","title":"Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03216057","title":"Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.","phase":"NA","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Hospital Infantil de Mexico Federico Gomez","has_results":true},{"nct_id":"NCT05355402","title":"A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07200674","title":"Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT03527069","title":"Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"EMS","has_results":false},{"nct_id":"NCT05685017","title":"Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Universitas Airlangga","has_results":false},{"nct_id":"NCT04221217","title":"Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Mochida Pharmaceutical Company, Ltd.","has_results":false},{"nct_id":"NCT02300233","title":"The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03385239","title":"Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Akcea Therapeutics","has_results":true},{"nct_id":"NCT03783377","title":"Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":false},{"nct_id":"NCT06471543","title":"Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":108,"lead_sponsor_name":"Ikaria Bioscience Pty Ltd","has_results":false},{"nct_id":"NCT03371355","title":"Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Akcea Therapeutics","has_results":true},{"nct_id":"NCT07505043","title":"First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"SUNHO（China）BioPharmaceutical CO., Ltd.","has_results":false},{"nct_id":"NCT05096455","title":"Hypertriglyceridemia Associated Acute Pancreatitis in Intensive Care Unit and Therapeutic Plasmapheresis","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04966494","title":"Impact of Beans and Oats Snack Bar on Hypertriglyceridemic Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Universidad Autonoma de Queretaro","has_results":false},{"nct_id":"NCT06323252","title":"A Study on the Effects of Mastiha Oil in Adults With Hypertriglyceridemia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Harokopio University","has_results":false},{"nct_id":"NCT04177680","title":"Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Matinas BioPharma Nanotechnologies, Inc.","has_results":true},{"nct_id":"NCT04630366","title":"A Phase 1, First Time in Humans Study of NST-1024","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"NorthSea Therapeutics B.V.","has_results":false},{"nct_id":"NCT03747224","title":"Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":false},{"nct_id":"NCT04419688","title":"A First in Human Study of STT-5058, an Antibody That Binds ApoC3","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":93,"lead_sponsor_name":"Staten Biotechnology BV","has_results":false},{"nct_id":"NCT04541186","title":"Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"89bio, Inc.","has_results":true},{"nct_id":"NCT06494488","title":"Differential Thrombogenesis by EPA and DHA Mediated by HDL","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"The Miriam Hospital","has_results":false},{"nct_id":"NCT04143971","title":"Intermittent Fasting in Hypertriglyceridemic Overweight or Obese Subjects","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Shahid Beheshti University","has_results":false},{"nct_id":"NCT02926027","title":"Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","has_results":true},{"nct_id":"NCT06555640","title":"A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Zhejiang Doer Biologics Co., Ltd.","has_results":false},{"nct_id":"NCT02354976","title":"A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04275622","title":"The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy Outcome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}